Long-term clinical and immunological effects of probiotic and peanut oral immunotherapy after treatment cessation: 4-year follow-up of a randomised, double-blind, placebo-controlled trialKuang‐Chih Hsiao, Ee Lyn Su, Anne‐Louise Ponsonby et al.|The Lancet Child & Adolescent Health|2017Cited by 158
Probiotic peanut oral immunotherapy is associated with long‐term persistence of 8‐week sustained unresponsiveness and long‐lasting quality‐of‐life improvementPaxton Loke, Mimi L.K. Tang, Adriana Chebar Lozinsky et al.|Clinical & Experimental Allergy|2022Cited by 11
Health-related quality of life outcomes in a Phase 2b Randomized Trial evaluating the effectiveness and safety of Probiotic Peanut Oral ImmunotherapyMelanie Lloyd, Mimi L.K. Tang, Adriana Chebar Lozinsky et al.|Journal of Allergy and Clinical Immunology|2022Cited by 0